Phendimetrazine Tartrate Capsule, Extended Release
Product Images NDC 72989-409

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Phendimetrazine Tartrate (NDC 72989-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acertis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

Chemical structure diagram of Phendimetrazine Tartrate showing its molecular formula C12H17NO and the tartrate component C4H6O6, with a molecular weight of 341.36.*

FDA Label Image

Body Mass Index Table (Image 02)

A data table showing Body Mass Index (BMI) values in kg/m² correlated with weight (pounds) and height (feet, inches). The table displays BMI numbers across different height and weight combinations, highlighting BMI ranges typically from 18 to 49.*

FDA Label Image

30-count Bottle Label (Image 03)

Label for Phendimetrazine Tartrate Extended-Release Capsules, 105 mg, oral dosage form by Acertis Pharmaceuticals, LLC. The label includes dosing information, storage instructions, a barcode, and states the container holds 30 capsules. The label emphasizes child safety and proper storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.